Spruce Biosciences separates CRHX-101 program into Adrenyx Biosciences, plans spin-off to stockholders

Spruce Biosciences is separating its CRHX-101 program into a new company, Adrenyx Biosciences, and plans to spin it off to stockholders.

Detected & updated continuously · Source: Nebula